Your browser doesn't support javascript.
loading
A phase I study of AZD2171 and Temsirolimus in patients with advanced gynecological malignancies.
Campos, Susana M; Berlin, Suzanne; Krasner, Carolyn N; Whalen, Christin; Atkinson, Tina; Meegan, Kristin; Pereira, Lauren; Tyburski, Karin; Lou, Weixiu; Lee, Hang; Horowitz, Neil; Penson, Richard T.
Afiliación
  • Campos SM; Division of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02115, USA. scampos@partners.org.
  • Berlin S; Division of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02115, USA.
  • Krasner CN; Division of Hematology Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Whalen C; Division of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02115, USA.
  • Atkinson T; Division of Hematology Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Meegan K; Division of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02115, USA.
  • Pereira L; Division of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02115, USA.
  • Tyburski K; Division of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02115, USA.
  • Lou W; Department of Biostatistics, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Lee H; Department of Biostatistics, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Horowitz N; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, USA.
  • Penson RT; Division of Hematology Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
Cancer Chemother Pharmacol ; 89(3): 423-430, 2022 03.
Article en En | MEDLINE | ID: mdl-35142863

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de los Genitales Femeninos Límite: Female / Humans Idioma: En Revista: Cancer Chemother Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de los Genitales Femeninos Límite: Female / Humans Idioma: En Revista: Cancer Chemother Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos